Government Clears Price Hike for Key Chemotherapy Drugs Amid Supply Concerns

India’s government has cleared a price revision for key chemotherapy drugs amid reported shortages of cisplatin and carboplatin across hospitals. According to Business Today’s Neetu Chandra Sharma, doctors flagged supply constraints affecting first-line cancer treatments for lung, ovarian, cervical, head and neck, and testicular cancers. The shortage is linked to a sharp rise in platinum, a key raw material, which has nearly doubled over the past year, increasing production costs for manufacturers of price-controlled medicines. Pharmaceutical companies have approached regulators seeking ceiling price revisions and relief on import duties. National Pharmaceutical Pricing Authority is expected to rework prices under the Drug Price Control Order. May ease supply pressures but could raise patient costs, raising affordability and access concerns in India.